ESAR - European Surveillance of Antibiotic Resistance
All in-patients; infection and discipline known; 1999 and 2000
Infections and Outcome

  Outcome Total
Responder Non-Responder
Cure of infection or FUO Improvement of infection Total No change Condition worsened Patient died during treatment Total
N % N % N % N % N % N % N % N %
Infection 8 44.44 4 22.22 12 66.67 2 11.11 1 5.56 3 16.67 6 33.33 18 100.00
FUO
Respiratory Tract 67 19.82 102 30.18 169 50.00 93 27.51 8 2.37 68 20.12 169 50.00 338 100.00
Sepsis/ Septic Shock 2 9.09 6 27.27 8 36.36 7 31.82 - - 7 31.82 14 63.64 22 100.00
Urinary tract infection 137 39.60 124 35.84 261 75.43 59 17.05 6 1.73 20 5.78 85 24.57 346 100.00
Intra-abdominal infection 7 33.33 5 23.81 12 57.14 7 33.33 - - 2 9.52 9 42.86 21 100.00
Skin/ soft Tissue 38 22.62 43 25.60 81 48.21 65 38.69 2 1.19 20 11.90 87 51.79 168 100.00
Wound infection 47 21.96 54 25.23 101 47.20 92 42.99 3 1.40 18 8.41 113 52.80 214 100.00
Positive blood culture 17 27.87 15 24.59 32 52.46 12 19.67 1 1.64 16 26.23 29 47.54 61 100.00
Bone-/joint infection - - 2 40.00 2 40.00 3 60.00 - - - - 3 60.00 5 100.00
multiple 1 2.27 10 22.73 11 25.00 27 61.36 2 4.55 4 9.09 33 75.00 44 100.00
Total 324 26.19 365 29.51 689 55.70 367 29.67 23 1.86 158 12.77 548 44.30 1237 100.00

ESBiC Study Center